The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results

Wednesday, November 03, 2010

Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results09:00 EDT Wednesday, November 03, 2010HOUSTON, Nov. 3, 2010 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the second quarter ended October 29, 2010 of its fiscal year ending April 29, 2011 on Monday, November 22, 2010 at 8:00 AM ET.  The company will conduct a conference call to discuss those results on the same day at 9:00 AM ET .Fiscal Year 2011 Second Quarter Results Conference Call InstructionsTo listen to the conference call live by telephone dial 877-313-8035 (if dialing from within the U.S.) or 706-679-4838 (if dialing from outside the U.S.).  The conference ID is 22043442.  Presentation slides will be available on-line at www.cyberonics.com no later than 8:00 AM ET on Monday, November 22, 2010.  A replay of the conference call will be available approximately two hours after the completion of the conference call by dialing 800-642-1687 (if dialing from within the U.S.) or 706-645-9291 (if dialing from outside the U.S.).  The replay conference ID access code is 22043442.  The replay will be available for one week on the above number and subsequently on the company's website for a period of six months.About Cyberonics, Inc. and VNS Therapy®Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation.  The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.Additional information on Cyberonics and VNS Therapy is available at www.cyberonics.com.CONTACT INFORMATION:Greg Browne, CFOCyberonics, Inc.100 Cyberonics Blvd.Houston, TX 77058Main:  (281) 228-7262Fax:  (281) 218-9332ir@cyberonics.comSOURCE Cyberonics, Inc.For further information: Greg Browne, CFO of Cyberonics, Inc., +1-281-228-7262, Fax, +1-281-218-9332, ir@cyberonics.com